Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment.
Iris K MinichmayrSebastian Georg WichaPeter MatznellerCharlotte KloftMarkus ZeitlingerPublished in: Clinical pharmacokinetics (2023)
The analysis calls to mind consideration of dose increases when prolonging the infusion duration in the case of low bacterial susceptibility.